Thursday 12 November 2026 Export INCY’s income statement to Excel — free account

Incyte Corporation

INCY

Healthcare Biotechnology

Incyte Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 21.2% from fiscal 2024.

Revenue: +14.0%
EPS: −277.9%
Free cash flow: −233.0%
Total debt: −10.5%

Quarter to September 2026, against a year earlier

121.89 0.38 −0.31%

Follow INCY

Alert me

Market cap: $24.9B
P/E: 58.1×
Fwd P/E: 57.3×
Dividend yield: —
F-score: 9/9
ROIC: 21.6%
Net debt / EBITDA: −2.2×
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Incyte Corporation (INCY) Book value per share

Alert me on Book value per share

Incyte Corporation's book value per share at the end of fiscal 2025 was 26.5×, up 59.0% from 16.6× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 27.8×. Over the past ten years it has ranged from 1.0× (fiscal 2015) to 26.5× (fiscal 2025) — the current reading is the highest in ten years. Incyte Corporation ranks 23rd of 611 Biotechnology companies by book value per share.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/INCY/book-value-per-share" width="100%" height="360" style="border:0" loading="lazy" title="Incyte Corporation book value per share, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/INCY/metrics/book-value-per-share">Incyte Corporation (INCY) book value per share — stockrow.com</a></p>

Period	Book value per share	Change
FY2025	26.5×	59.03%
FY2024	16.6×	(28.27%)
FY2023	23.2×	17.89%
FY2022	19.7×	15.10%
FY2021	17.1×	42.83%
FY2020	12.0×	(0.96%)
FY2019	12.1×	33.33%
FY2018	9.1×	13.77%
FY2017	8.0×	256.99%
FY2016	2.2×	134.28%

Period	Book value per share	Change
Sep 2026	27.8×	(12.31%)
Jun 2026	31.7×	12.25%
Mar 2026	28.2×	6.55%
Dec 2025	26.5×	11.37%
43 more quarters	Free account

Against its own ten years

Low 1.0× High 26.5×

Ten-year median 12.1×

Current reading's percentile 100

Company	Book value per share
BNTX BioNTech SE Sponsored ADR compare	81.8×
JAZZ Jazz Pharmaceuticals PLC compare	64.8×
INCY Incyte Corporation	27.8×
ALNY Alnylam Pharmaceuticals, Inc. compare	26.9×
ASND Ascendis Pharma A/S compare	26.0×
GMAB Genmab A/S Sponsored ADR compare	10.3×
EXEL Exelixis, Inc. compare	7.4×
ROIV Roivant Sciences Ltd. compare	6.4×
INSM Insmed, Inc. compare	3.3×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

Incyte Corporation (INCY) Book value per share

Book value per share, annual

Annual newest first

Quarterly newest first

Against its own ten years

Book value per share against peers

What Book value per share is

More on INCY

Book value per share, annual

Annual newest first

Quarterly newest first

Against its own ten years

Book value per share against peers

What Book value per share is

More on INCY

Stockrow Weekly